business

Barclays reiterates uniQure stock rating after FDA meeting update

Investing.com · Jun 17, 2026, 2:05 PM · Also reported by 2 other sources

Read full story on Investing.com → More top stories

Also covered by

Yahoo Finance Barclays Maintains Overweight Rating on Dollar General (DG) Yahoo Finance H.C. Wainwright Reiterates Buy Rating for Structure Therapeutics (GPCR)

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Barclays reiterates uniQure stock rating after FDA meeting update

Also covered by

More in business